Skip to main content

Table 1 Baseline characteristics

From: Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention

 

n (%) or mean ± standard deviation

Age (years)

65.0 ± 8.2

Hypertension

34 (91.9%)

Diabetes

12 (32.4%)

Obesity

5 (13.5%)

Currently smoking

4 (10.8%)

Chronic kidney failure

3 (8.1%)

History of acute coronary syndrome

19 (51.4%)

Prior percutaneous coronary intervention

12 (32.4%)

Prior coronary artery bypass surgery

2 (5.4%)

Medications

 Aspirin

35 (94.6%)

 Clopidogrel

25 (67.6%)

 Angiotensin-converting enzyme inhibitors

6 (16.2%)

Angiotensin receptor blockers

21 (56.8%)

 Beta-blocker

30 (81.1%)

 Statin

31 (60.8%)

Number of coronary arteries with ≥ 50% obstruction

 1

12 (32.4%)

 2

14 (37.8%)

 3

11 (29.7%)

Number of stents (median)

2

EPC count before PCI (cells/mcl)

320

  1. EPCs endothelial progenitor cell